spot_img

about fansalaran

FanSalaran is a comprehensive media platform dedicated to reporting and clarifying the significant achievements of pharmaceutical companies. In collaboration with passionate and motivated young journalists, this website consistently strives to showcase the country's successes in order to inspire and encourage the hardworking individuals of this land.

dorost

Intuitive Surgical reports upbeat quarterly earnings on strong demand for surgical robots

Intuitive Surgical (ISRG.O), opens new tab beat Wall Street estimates for second-quarter profit and revenue on Tuesday, driven by...

US FDA extends review of GSK’s blood cancer drug

The U.S. Food and Drug Administration has extended its review of GSK's (GSK.L), opens new tab blood cancer drug,...

India’s Dr Reddy’s plans to launch generic obesity drugs in 87 countries next year, CEO says

Dr Reddy's Laboratories (REDY.NS), opens new tab plans to launch a cheaper copycat version of Novo Nordisk's (NOVOb.CO), opens...

Indonesian military’s new pharma role sparks fears of expanded powers

Indonesia's military will begin manufacturing medicines for public distribution under a new agreement, officials said on Tuesday, in the...

Lutein and Zeaxanthin Market 2025 Trends: Expected to Grow at a CAGR of 4.9% from 2025 to 2031, Claims AMR

Lutein, zeaxanthin, and meso-zeaxanthin are three carotenoids that are specifically concentrated in the human macula. Lutein and zeaxanthin are...

France’s Sanofi to acquire biotech firm Vicebio for $1.15 billion

French pharmaceuticals company Sanofi (SASY.PA), opens new tab said on Tuesday it would acquire British private biotechnology firm Vicebio...
spot_imgspot_img

George Medicines signs exclusive licensing agreement with Azurity Pharmaceuticals to commercialize WIDAPLIK™ (telmisartan, amlodipine and indapamide) tablets in the US

• An innovative single pill combination of three medicines, including two doses that are lower than those currently available...

AstraZeneca unveils $50 billion US investment as pharma tariff threat looms

AstraZeneca (AZN.L), opens new tab plans to spend $50 billion to expand manufacturing and research capabilities in the U.S....

Afghanistan Sees Expansion of Domestically Produced Pharmaceuticals

A number of local pharmaceutical companies are at the forefront of increasing the domestic share of the lucrative pharmaceutical...

Biogen beefs up North Carolina manufacturing ahead of potential drug tariff storm

Biogen (BIIB.O), opens new tab will invest $2 billion more in its existing manufacturing plants in North Carolina, the...

Many US ice cream producers to phase out artificial food dyes by 2028

Dozens of U.S. ice cream producers are planning to remove artificial colors from their products by 2028, a dairy...

Fifty times more people to ‘die from heat-related deaths in England by 2070

Fifty times more people could die from heat-related deaths in England and Wales by the 2070s due to climate...